NASDAQ · Price History

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) Price History & Returns

$6.47 NASDAQ: SVA Market Cap $464.94M

How Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

A beta of 0.00 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months+0.0%
6 months+0.0%
1 year+0.0%
3 years+0.0%
5 years+0.0%

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) price history — frequently asked questions

How has Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) performed over the last year?

Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) has risen 0.0% over the last twelve months, measured on price alone.

What is Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo)'s five-year return?

Over five years the SVA share price has gained 0.0%, excluding dividends.

What is Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo)'s 52-week range?

Over the last year Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) has traded between $6.47 and $6.47.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.